Apple and Eli Lilly have partnered with healthtech start-up Evidation for an early-stage, 12-week study assessing whether Apple's technology could help detect signs of cognitive decline. Data was collected via iPhone, Apple Watch, iPad and Apple-owned Beddit's sleep monitoring device, with initial results suggesting the devices could identify behaviours including increased reliance on helper apps. Dementia affects five people worldwide and costs $1tn, according to the World Health Organization.
Apple and Eli Lilly have partnered with healthtech start-up Evidation for an early-stage, 12-week study assessing whether Apple's technology could help detect signs of cognitive decline. Data was collected via iPhone, Apple Watch, iPad and Apple-owned Beddit's sleep monitoring device, with initial results suggesting the devices could identify behaviours including increased reliance on helper apps. Dementia affects approximately 47 million people worldwide and costs $1tn, according to the World Health Organization.